Novel Function of MeCP2 Protein Could Be Route to Rett Therapy, Study Suggests
Australian Disability Marks International Day of People with Disabilities 2024
NDIS Coverage: Understanding the Supported Services
CripChat Australia #198: Beyond the NDIS: Services and Supports for People with Disabilities
CripChat Australia #197: Quality and Safeguard Reforms – Will They Protect People with Disabilities?
Australian Disability Limited
Send Us your News and/or Sports Tip:
1 in 5 Australians are struggling with mental health – what does this mean for ECEC?
Researchers develop a novel method for diagnosing Duchenne Muscular Dystrophy
How to Deal Anxiety
Potential Sanfilippo Treatment, SLS-005, Advances as Orphan Drug in EU
Dylan Alcott tells Kurt Fearnley on One Plus One how sport opened doors, and maybe saved his life
Disability royal commission data shows Indigenous and culturally diverse groups under-represented
Inflammatory Markers May Help Predict Exacerbations in Children with Cystic Fibrosis
Tofersen Safe, Appears to Slow Disease Progression in SOD1 ALS Patients, Phase 1/2 Trial Shows
Beyond Blue encourages educators to put themselves first and guard mental health
Tysabri Use Can Lessen Disability in RRMS Patients, Real-world Study Reports
Chronic fatigue syndrome may hold keys to understanding post-Covid syndrome
No, You Aren’t a ‘Savage’ for Being Unable to Return That Cart
ALS scientific breakthrough: Diabetes drug metformin shows promise in mouse study for a common type
JobTrainer may have potential to boost disability workforce
New Technology Offers Potential for Faster, More Accurate CF Diagnosis
Hansa Licenses Imlifidase to Sarepta as Gene Therapy Pre-treatment for DMD, LGMD
BRD4 Protein May be Therapeutic Target for Rett Syndrome, Study Suggests
Hansa Licenses Imlifidase to Sarepta as Gene Therapy Pre-treatment for DMD, LGMD
Drug for Rare Form of ALS Shows Promise